M
yocarditis is an inflammatory status in the heart. Symptoms of myocarditis include chest pain, shortness of breath, irregular heartbeat, and decreased ability to exercise. 1 Myocarditis may develop into heart failure because of dilated cardiomyopathy or cardiac arrest. 1 Fortunately, most myocarditis can heal without sequels. Histological signs of myocarditis can be found in 3% to 6% of the general population. 2 The causative factors of myocarditis include autoimmunity, viral infection, bacterial infection, and toxins. 3 The treatment of myocarditis focuses on symptom control, including using an angiotensin-converting-enzyme inhibitor, β-blockers, and diuretics. Corticosteroids are also useful in some cases. 4, 5 Yet the treatment of myocarditis is largely unsatisfactory currently.
1 Some myocarditis cases eventually develop into heart failure 6 and result in the need for heart transplantation. 7 Autoimmunity is a condition caused by an abnormal immune response in the body, and it plays a critical role in the pathogenesis of myocarditis, 8 in which the T cells and B cells aberrantly respond to the self-antigens in the body, release a large quantity of cytokines, and cause tissue injury. 9 Using cardiac myosin heavy-chain (MyHC)-α as a specific antigen to immunize mice, myocarditislike inflammation can be induced. 10 In this myocarditis murine model, abundant MyHC-α-specific CD4 + T cells infiltrate into the heart tissue. 10 Such a phenomenon suggests that a large number of naïve CD4 + T cells differentiate into mature CD4 + T cells, and the activationinduced cell death (AICD) mechanism is compromised in the CD4 + T cells. 11 Interleukin (IL)-4 is the signature cytokine of Th2 polarization. 12 It in turn induces more IL-4 expression and induces other Th2 cytokine, such as IL-5 and IL-13, expression in CD4 + T cells. 12 IL-4 plays a central role in the production of immunoglobulin E, 13 which is a key mediator of mast cell activation. 14 The actions of IL-4 and immunoglobulin E enhance the reactivity of eosinophils. 15 Both mast cells and eosinophils play roles in the pathogenesis of heart inflammation. 16 Yet the mechanism of this phenomenon in myocarditis hearts remains to be further investigated.
Published data indicate that the Bcl2-like protein 12 (Bcl2L12) compromises immune tolerance. 17, 18 Bcl2L12 belongs to the Bcl2 family; it is an anti-apoptotic protein. Previous studies found that Bcl2L12 suppressed p53 to facilitate tumor cell survival. 19 Considering that immune tolerance is also compromised in myocarditis, 10 we hypothesize that Bcl2L12 may play a role in the induction of myocarditis. In this study, we found that the CD4 + T cells in myocarditis hearts expressed high levels of Bcl2L12. Naïve CD4 + T cells from myocarditis hearts were prone to differentiate into Th2 cells. The Bcl2L12 inhibited the expression of p53 and caused the apoptotic machinery in CD4 + T cells of the myocarditis hearts to become defective.
METHODS
The data, analytic methods, and study materials described in this article will be available in this article and in our laboratory to other researchers for purposes of reproducing the results or replicating the procedure. We will be responsible for maintaining availability.
Human Heart Sample Collection
The human heart samples were collected at surgical operation room from patients who had undergone heart transplantation. The patients were divided into 2 groups: the myocarditis group and the dilated cardiomyopathy (Dcm; without myocarditis) group. The demographic data are presented in Table 1 . Histologically, none of the heart samples of the Dcm group showed inflammation in the heart tissue. All the patients suffered from advanced heart failure and underwent routine treatment, but fewer responded to the therapies. The decision to undergo heart transplantation was made by our surgeons and agreed to by the patients. Tissue samples were taken from each explanted heart to be examined by real-time quantitative polymerase chain reaction. None of the samples showed a positive sign of virus infection (experimental procedures and primers are presented in Table I in the online-only Data Supplement). Patients who had used immune suppressors within the last year were excluded from the present study. The use of human tissue in the present study was approved by the Human Ethics Committee at Beijing Fuwai Hospital. Written informed consent was obtained from each patient.
Clinical Perspective
What Is New?
• The expression of Bcl2-like protein 12 (Bcl2L12) was detected in CD4 + T cells of the surgically removed hearts, which was markedly higher in the hearts with myocarditis at the advanced stage of heart failure compared with the control (dilated cardiomyopathy) hearts without myocarditis.
• Mice with Bcl2L12-deficient CD4 + T cells failed to induce the T helper-2-biased inflammation in the heart.
• CD4 + T cells with a higher expression of Bcl2L12 were prone to differentiate into T helper-2 cells.
• Bcl2L12 interacted with GATA binding protein 3 to enhance the Il4 gene transcription.
• Bcl2L12 compromised the apoptotic machinery to reduce the activation-induced CD4 + T cell death.
What Are the Clinical Implications?
• CD4 + T cells isolated from hearts with myocarditis at the end stage of heart failure express high levels of Bcl2L12; the latter is required for the aberrant T helper-2 polarization in the heart.
• The Bcl2L12 may be a novel target in the treatment of myocarditis and other T helper-2-biased inflammation.
Mice
The BALB/c mice (wild type [WT]; 6 to 8 weeks of age) were purchased from the Beijing Experimental Animal Center. The Bcl2L12 knockout (KO) mice with a BALB/c background (the source of the mouse strain was the same as the WT littermates) were provided by the Animal Institute at the Chinese Agricultural Academy ( Figure I in the online-only Data Supplement). The Bcl2L12 gene KO status in CD4 + T cells is presented in Figure I in the online-only Data Supplement. The mice were maintained in a specific pathogen-free facility with free access to food and water. The use of mice in the present study was approved by the Animal Ethics Committee at Beijing Fuwai Hospital. Procedures were in accordance with institutional guidelines.
Induction of Th2-Biased Inflammation in the Heart
Following the published procedures 20 with modification, mice were immunized with the peptide of MyHC-α 614 to 629 (GL Biochem). The peptide (0.1 mg/mouse) was mixed with 0.1 mL alum using a 27-gauge needle under the dorsal skin on days 0 and 7. The mice were challenged with the peptides (0.5 mg/mouse in 0.1 mL saline via intraperitoneal injection) on days 11 and 13. The mice were euthanized on day 14. 
Induction of AICD and Assessment of Apoptosis

Statistics
The data are presented as mean±SD or mean±SEM. Differences between the 2 groups were tested using Student t test or ANOVA, followed by Student-Newman-Keuls test or Dunnett t test for multiple comparisons. P<0.05 was considered statistically significant.
Some experimental procedures are presented in the online-only Data Supplement.
RESULTS
Bcl2L12 KO Mice Fail to Develop Th2-Biased Inflammation in the Heart
Following the published procedures, 20 mice with Bcl2L12-deficient CD4 + T cells (Figures I through III in the online-only Data Supplement; hereafter, Bcl2L12 KO mice) and the littermates, BALB/c mice (WT mice), were treated with the MyHC-α peptides; alum was used as the adjuvant. The WT mice showed significant ventricular tachycardia and QRS-wave abnormalities ( Figure 1A ) and body weight loss ( Figure 1B ). The Th2-biased inflammation, including profound mononuclear infiltration in the heart tissue ( Figure 1C and 1D) and a Th2-dominant profile in the heart (high levels of Th2 cytokines/cells and lower levels of Th1 cytokines/cells in the heart) ( Figure 1E and 1F, Figure II in the online-only Data Supplement), was induced in the hearts of the WT mice but not in the hearts of the Bcl2L12 KO mice. To Values are n (%) or mean±SD.
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corroborate the results, Bcl2L12 KO mice were reconstituted with Bcl2L12-sufficient CD4 + CD25¯ T cells. The mice were immunized with MyHC-α. The Th2-biased inflammation was induced in the heart (Figure 1) . The results imply that Bcl2L12 plays a critical role in the development of the Th2-biased inflammation in the heart.
Bcl2L12 Positively Correlates With Th2 Response in the Hearts With Myocarditis and Advanced Cardiac Failure
Heart samples were collected from patients with advanced stage heart failure who had undergone heart transplantation with or without myocarditis. The heart tissue was examined by histology. CD4 + T cells were isolated from the heart samples and analyzed by flow cytometry and ELISA. Inflammatory signs, including profound inflammatory cell infiltration and tissue structure damage, were observed in the myocarditis heart samples (Figure 2A and 2B) . A Th2-dominant profile, including higher levels of Th2 cytokines, lower levels of interferon-γ, IL-17, and tumor necrosis factor in the heart tissue protein extracts ( Figure 2C ), higher frequencies of Th2 cells, and lower frequencies of interferon-γ + , IL-17 + , and tumor necrosis factor + cells in the mononuclear cells isolated from the heart tissue (Figure 2D) , was detected in the myocarditis heart samples compared with the Dcm heart (control hearts collected from patients who had undergone heart transplantation without myocarditis) samples. No giant cells were found in the heart samples of the myocarditis and Dcm groups.
Prompted by the data of Figure 1 that Bcl2L12 may be associated with the development of a Th2-dominant response in the heart, we purified CD4 + T cells from the human heart samples. The cells were analyzed by real-time quantitative polymerase chain reaction and Western blotting. The results showed that the CD4 + T cells expressed Bcl2L12, which was much higher in the myocarditis heart samples than that from the Dcm heart samples (Figure 2E WT mice and Bcl2L12 KO mice were treated with MyHCα peptides. A, ECG of MyHCα-treated WT mice shows significant ventricular tachycardia and QRS-wave abnormalities, which did not appear in KO mice. B, Body weight change of mice after treatment with MyHCα. C, Counts of mononuclear cells per gram heart tissue. D, Representative heart histology images show profound inflammatory cell infiltration in the heart tissue (×100). E, Cytokine (as denoted on the x axis) levels in mouse heart protein extracts. F, CD4 + T cell phenotypes in the mononuclear cells isolated from the mouse heart. #, KO mice were reconstituted with Bcl2L12-sufficient CD4 + T cells. Each group consists of 6 mice. Samples from individual mice were analyzed separately. The data of bars are presented as mean±SEM. . Anti-myosin antibodies were also detected in the heart tissue extracts, which were much higher in the myocarditis hearts than that in the Dcm hearts (Figure 2G) . The data indicate that CD4 + T cells from myocarditis hearts express higher levels of Bcl2L12; the Bcl2L12 may be involved in the pathogenesis of the Th2-dominant profile in the hearts with myocarditis.
Bcl2L12 Is Associated With the Tendency of CD4 + T Cells in Myocarditis Hearts to Differentiate Into Th2 Cells
The CD4 + T cells isolated from the myocarditis heart samples were further analyzed. The results showed that the expression of Bcl2L12 was expressed by CD4 + CD25 + T cells and was also highly expressed by the CD4 + CD25 -T cells ( Figure 3A) . We then purified the CD4 + CD25 − T cells from the myocarditis hearts. The cells were treated with T cell activators (phorbol 12-myristate 13-acetate/ionomycin) in the culture for 2 days. Significantly more IL-4 + CD4 + T cells were detected in the cells isolated from the myocarditis hearts compared with those isolated from the Dcm hearts ( Figure 3B The myocarditis hearts (n=12) and Dcm hearts (n=12) were collected from patients who had undergone heart transplantation. A, Representative histology images of the hearts (×100). B, Counts of mononuclear cells isolated from the heart samples. C, Cytokine levels in the heart tissue extracts. D, Frequencies of CD4 + T cell phenotypes in the heart (the histograms are presented in Figure I in the online-only Data Supplement). E and F, Expression of Bcl2L12 in CD4 + T cells isolated from the heart samples. G, Levels of anti-myosin antibody in the protein extracts of heart tissue. Samples from individual human subjects were analyzed separately. The data of bars are presented as mean±SEM. *P<0.01 (t test), compared with the Dcm samples. Bcl2L12 indicates Bcl2-like protein 12; IFN, interferon; IL, interleukin; Mcd, myocarditis; mRNA, messenger RNA; Dcm, dilated cardiomyopathy; MyHCα, myosin heavy-chain-α; Th2, T helper-2; TNF, tumor necrosis factor; and WT, wild type.
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CD4 + T cells with Bcl2L12 knockdown compared with cells treated with control RNA interference ( Figure 3C ). In contrast, CD4 + CD25 − T cells were prepared from the Dcm hearts. The cells expressed lower levels of Bcl2L12. We then transfected the Bcl2L12 gene-carrying plasmids to the cells to induce them to overexpress Bcl2L12 (Figure VB in the online-only Data Supplement). The CD4 + T cells with Bcl2L12 overexpression were then treated with the activators in the culture for 2 days. A high frequency of IL-4 + CD4 + T cells was induced ( Figure 3D ). The data demonstrate that Bcl2L12 plays a critical role in the development of the Th2 response.
Bcl2L12 Enhances the IL-4 Gene Transcription in CD4 + T Cells of the Heart Via Enhancing the Binding Between GATA3 and the Il4 Promoter
Next, CD4 + T cells isolated from myocarditis and Dcm hearts were analyzed by chromatin immunoprecipitation. Both Bcl2L12 and GATA3 were detected at the Il4 promoter locus, which were much higher in the myocarditis heart samples than in the Dcm heart samples ( Figure 4A ). The amounts of RNA polymerase II, the indicator of gene transcription, were markedly higher in the myocarditis samples than in the Dcm hearts ( Figure 4B ). The expression of IL-4 was also higher in the CD4 + T cells isolated from the myocarditis heart samples than those from the Dcm heart samples ( Figure 4C and 4D) . The data imply that Bcl2L12 may be an enhancer of Il4 gene transcription. Because both Bcl2L12 and GATA3 were detected at the Il4 promoter locus, we inferred that these 2 molecules might form a complex in CD4 + T cells. To test this theory, protein extracts were prepared with CD4 + T cells isolated from the heart samples and analyzed by immunoprecipitation. The results showed a complex of Bcl2L12 and GATA3 in CD4 + T cells, the amounts of which were much more in the cells of myocarditis samples than in the Dcm samples ( Figure 4E ). To corroborate the results, human embryonic kidney 293 cells were cotransfected with the Bcl2L12-and GATA3-expressing plasmids. As analyzed by immunoprecipitation, the recombinant Bcl2L12 and GATA3 formed a complex in human embryonic kidney 293 cells ( Figure 4F ). To elucidate whether Bcl2L12 regulates the expression of GATA3, we analyzed EL-4 cells. This cell line expresses GATA3 and produces IL-4 after activation. 21 The cells were knocked down the Bcl2L12 gene by RNA interference ( Figure 
Bcl2L12 Interferes With the Apoptotic Machinery in CD4 + T Cells of Myocarditis Hearts
Published data indicate that Bcl2L12 suppresses p53 to inhibit cancer cell apoptosis. 22 The data reported previously indicate that CD4 + T cells express high levels of Bcl2L12 in myocarditis hearts. We inferred that the Bcl2L12 might interfere with the apoptotic machinery in the CD4 + T cells. To test this theory, CD4 + T cells were isolated from myocarditis heart samples. The extracts were prepared from the cells and analyzed by real-time quantitative polymerase chain reaction and Western blotting. The results showed that the p53 and Fas levels were markedly lower in the CD4 + T cells of myocarditis hearts than those in the Dcm hearts ( Figure 5A through  5C) . The mRNA levels of p53 but not Fas were negatively + T cells was significantly lower in the myocarditis hearts than in the Dcm hearts after treating with the AICD-inducing procedures (Figure 5D) . The results suggest that Bcl2L12 may be responsible for the defective apoptotic machinery in the CD4 + T cells of the myocarditis hearts. To test this theory, CD4 + T cells were isolated from the myocarditis hearts. The Bcl2L12 gene was knocked down by RNA interference. The cells were treated with the AICD-inducing procedures. The results showed that the frequency of apoptotic CD4 + T cells was markedly increased (Figure 5E) , and the expression of p53 in CD4 + T cells was also increased ( 
DISCUSSION
In this study, we found that the Bcl2L12 is required for the aberrant Th2 polarization in the heart with myocarditis. CD4 + T cells isolated from the myocarditis heart showed higher expression of Bcl2L12. Naïve CD4 + T cells with high Bcl2L12 expression were prone to differentiate into Th2 cells. Bcl2L12 inhibited the expression of p53 to compromise the AICD in CD4 + T cells. The data demonstrate that Bcl2L12 promotes the differentiation of Th2 cells and compromises the apoptotic machinery in the CD4 + T cells to develop the aberrant Th2 polarization and the Th2-biased inflammation in the myocarditis hearts. Mice with Bcl2L12 KO failed to induce the Th2-biased inflammation in the heart.
Because myocarditis can be induced by various factors, such as viral infection, bacterial infection, or an autoimmune response, the resulted phenotypes of inflammation are also various from each other. 9 The present study observed a group of myocarditis hearts at the advanced stage of heart failure. The data showed a Th2-biased inflammatory status in the hearts. In ad- dition to finding the aberrant Th2 polarization in the heart tissue, we also found high levels of anti-myosin antibodies in the myocarditis heart tissue. The antimyosin antibody is an autoantibody; it can cause tissue damage by triggering apoptosis, activating the complement system, or initiating cell-mediated cytotoxicity. 23 The production of such an antibody in the heart mirrors the Th2-biased inflammatory status in the hearts. A large body of reports also demonstrate that anti-myosin antibodies can be observed in myocarditis induced by autoimmune responses. 24 The data show profound infiltration of Th2 cells in the myocarditis hearts at the advanced stage of heart failure. The Th2 cells are 1 of the signature cells in autoimmune inflammation. 25 Published data indicate that all the phenotypes of CD4 + T cells may play a causative role in the pathogenesis of myocarditis if they reach the polarization status. 26 Because the immune system has both Th1 and Th2 response machinery, the triggering factors may determine whether the inflammation develops to Th1 or Th2 dominant. The present data show that Bcl2L12 can be such a triggering factor: CD4 + T cells from myocarditis hearts express higher levels of Bcl2L12 and Bcl2L12-expressing CD4 + T cells are prone to differentiate into Th2 cells. Mice with Bcl2L12 KO failed to develop Th2-biased inflammation in the heart.
On activation, a part of T cells dies shortly; this phenomenon is called AICD. 27 The AICD machinery is compromised in a number of diseases, such as observed in asthma patients, 28 asthma mice, 29 and those with autoimmune diseases. 30 Thus, the defective AICD machinery may also contribute to the aberrant Th2 polarization status. The present data also show the feature of defective AICD in the myocarditis hearts because CD4 + T cells from the myocarditis hearts were less sensitive to the AICD-inducing procedures; they expressed less Fas and p53. Previous studies indicate that Bcl2L12 inhibits p53 to compromise the apoptotic machinery. 19, 22 Our data also demonstrate that the expression of Bcl2L12 in CD4 + T cells is negatively correlated with the expression of p53 but not Fas. Although a large number of reports indicate that the defective Fas/FasL system plays a critical role in the defective of AICD, 31 defective p53 is also observed to play an essential role in the defective AICD. 32, 33 In contrast, IL-4 also downregulates the susceptibility of CD8 + T cells to AICD partially via maintaining the level of the anti-apoptotic protein Bcl-2. 34 Whether Bcl2L12 induces the apoptosis-resistant feature in CD4 + T cells, as we observed in the present study, also partially via maintaining Bcl-2 or even via maintaining Bcl2L12, remains to be further investigated.
CONCLUSIONS
In summary, the present data show that CD4 + T cells from the myocarditis hearts express high levels of Bcl2L12. CD4 + T cells with higher Bcl2L12 expression are prone to differentiate into Th2 cells. The expression of Bcl2L12 also inhibits p53 expression to compromise the AICD machinery. Thus, we conclude that Bcl2L12 plays a critical role in the induction of Th2-biased inflammation in the heart by enhancing IL-4 expression and reducing the AICD in CD4 + T cells. Bcl2L12 may be a novel therapeutic target in the management of myocarditis and other disorders with Th2-biased inflammation.
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